These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38419411)

  • 1. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.
    Ramessur R; Dand N; Langan SM; Saklatvala J; Fritzsche MC; Holland S; Arents BWM; McAteer H; Proctor A; McMahon D; Greenwood M; Buyx AM; Messer T; Weiler N; Hicks A; Hecht P; Weidinger S; Ndlovu MN; Chengliang D; Hübenthal M; Egeberg A; Paternoster L; Skov L; De Jong EMGJ; Middelkamp-Hup MA; Mahil SK; Barker JN; Flohr C; Brown SJ; Smith CH
    Br J Dermatol; 2024 Jun; 191(1):14-23. PubMed ID: 38419411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping ethical and social aspects of biomarker research and its application in atopic dermatitis and psoriasis: a systematic review of reason.
    Fritzsche MC; Buyx AM; Hangel N
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1201-1213. PubMed ID: 35366351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
    Silverberg JI; Gooderham MJ; Paller AS; Deleuran M; Bunick CG; Gold LFS; Hijnen D; Calimlim BM; Lee WJ; Teixeira HD; Hu X; Zhang S; Yang Y; Grada A; Platt AM; Thaçi D
    Am J Clin Dermatol; 2024 May; 25(3):485-496. PubMed ID: 38528257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis.
    Dainty KN; Thibau IJC; Amog K; Drucker AM; Wyke M; Begolka WS
    Br J Dermatol; 2024 Jun; 191(1):82-91. PubMed ID: 38287887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases.
    Alenius H; Sinkko H; Moitinho-Silva L; Rodriguez E; Broderick C; Alexander H; Reiger M; Hjelmsø MH; Fyhrquist N; Olah P; Bryce P; Smith C; Koning F; Eyerich K; Greco D; van den Bogaard EH; Neumann AU; Traidl-Hoffmann C; Homey B; Flohr C; Bønnelykke K; Stokholm J; Weidinger S
    Exp Dermatol; 2021 Oct; 30(10):1517-1531. PubMed ID: 34387406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.
    Ziehfreund S; Tizek L; Hangel N; Fritzsche MC; Weidinger S; Smith C; Bryce PJ; Greco D; van den Bogaard EH; Flohr C; Rastrick Ucb J; Eyerich S; Buyx A; Conrad C; Eyerich K; Zink A
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1467-1476. PubMed ID: 35470457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
    J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.
    Egeberg A; Thyssen JP
    J Am Acad Dermatol; 2019 Oct; 81(4):943-949. PubMed ID: 31202869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients.
    Torisu-Itakura H; Anderson P; Piercy J; Pike J; Sakamoto A; Kabashima K
    Curr Med Res Opin; 2022 Aug; 38(8):1401-1410. PubMed ID: 35787197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults.
    Egeberg A; Griffiths CEM; Williams HC; Andersen YMF; Thyssen JP
    Br J Dermatol; 2020 Jul; 183(1):128-138. PubMed ID: 31630393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
    Wollenberg A; Gooderham M; Katoh N; Aoki V; Pink AE; Binamer Y; Silverberg JI
    Arch Dermatol Res; 2024 Jun; 316(7):380. PubMed ID: 38850461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care.
    Maintz L; Bieber T; Bissonnette R; Jack C
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1473-1486.e2. PubMed ID: 33838840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity.
    Chernyshov PV
    G Ital Dermatol Venereol; 2016 Feb; 151(1):37-43. PubMed ID: 24927171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
    Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
    Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe.
    Augustin M; Misery L; von Kobyletzki L; Armario-Hita JC; Mealing S; Redding M
    J Eur Acad Dermatol Venereol; 2022 Jul; 36 Suppl 7():3-16. PubMed ID: 35801296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.